Back
Maravai LifeSciences Holdings Quote, Financials, Valuation and Earnings
Sell
27
MRVI
Maravai LifeSciences Holdings
Last Price:
7.53
Seasonality Move:
-9.93%
7 Day Trial
ALL ACCESS PASS
$
7
Maravai LifeSciences Holdings Price Quote
$7.53
-0.23 (-2.96%)
(Updated: June 14, 2024 at 6:50 PM ET)
Maravai LifeSciences Holdings Key Stats
Sell
27
Maravai LifeSciences Holdings (MRVI)
is a Sell
Day range:
$7.69 - $7.89
52-week range:
$4.52 - $14.21
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.74
P/B ratio:
2.51%
Volume:
1.1M
Avg. volume:
2M
1-year change:
-46.99%
Market cap:
$1B
Revenue:
$288.9M
EPS:
$-0.99
How Much Does Maravai LifeSciences Holdings Make?
-
How Much Are Maravai LifeSciences Holdings's Sales Annually?
MRVI Revenues are $288.9M -
How Much Profit Does Maravai LifeSciences Holdings's Make A Year?
MRVI net income is -$119M
Is Maravai LifeSciences Holdings Growing As A Company?
-
What Is Maravai LifeSciences Holdings's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.19% -
What Is Maravai LifeSciences Holdings's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Maravai LifeSciences Holdings Stock Price Performance
-
Did Maravai LifeSciences Holdings Stock Go Up Last Month?
Maravai LifeSciences Holdings share price went down by -26.31% last month -
Did MRVI's Share Price Rise Over The Last Year?
MRVI share price fell by -46.99% over the past 1 year
What Is Maravai LifeSciences Holdings 52-Week High & Low?
-
What Is Maravai LifeSciences Holdings’s 52-Week High Share Price?
Maravai LifeSciences Holdings has traded as high as $14.21 over the past 52 weeks -
What Is Maravai LifeSciences Holdings’s 52-Week Low Share Price?
Maravai LifeSciences Holdings has traded as low as $4.52 over the past 52 weeks
Maravai LifeSciences Holdings Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Maravai LifeSciences Holdings?
-
How Much Debt Does Maravai LifeSciences Holdings Have?
Total long term debt quarterly is $523.3M -
How Much Cash Does Maravai LifeSciences Holdings Have?
Cash and short term investments quarterly total is $561.7M -
What Is Maravai LifeSciences Holdings’s Book Value Per Share?
Book value per share is 3.10
Is Maravai LifeSciences Holdings Cash Flow Positive?
-
What Is MRVI Cash Flow From Operations?
Cash flow from operations (TTM) is $32.7M -
What Is Maravai LifeSciences Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$42.4M -
What Is Maravai LifeSciences Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$56.8M
Maravai LifeSciences Holdings Return On Invested Capital
-
Is Management Doing A Good Job?
MRVI return on invested capital is -9.52% -
What Is Maravai LifeSciences Holdings Return On Assets?
ROA measures how assets are converting to revenues and is -6.7% -
What Is MRVI Return On Equity?
ROE is a measure of profitability and is -15.39%
Maravai LifeSciences Holdings Earnings Date & Stock Price
-
What Is Maravai LifeSciences Holdings's Stock Price Today?
A single share of MRVI can be purchased today for 7.76 -
What Is Maravai LifeSciences Holdings’s Stock Symbol?
Maravai LifeSciences Holdings trades on the nasdaq under the ticker symbol: MRVI -
When Is Maravai LifeSciences Holdings’s Next Earnings Date?
The next quarterly earnings date for Maravai LifeSciences Holdings is scheduled on August 7, 2024 -
When Is MRVI's next ex-dividend date?
Maravai LifeSciences Holdings's next ex-dividend date is June 14, 2024 -
How To Buy Maravai LifeSciences Holdings Stock?
You can buy Maravai LifeSciences Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Maravai LifeSciences Holdings Competitors
-
Who Are Maravai LifeSciences Holdings's Competitors?
Below is a list of companies who compete with Maravai LifeSciences Holdings or are related in some way:
Maravai LifeSciences Holdings Dividend Yield
Data Unavailable
Maravai LifeSciences Holdings Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 23.23% |
Revenue: | -18.79% | 6% |
Analyst Recommendations
Buy Recommendations: | 8 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 10.42 |
Upside from Last Price: | 34.29% |